Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type (2 selected)

Type

Guidance programme (11 selected)

Guidance programme

Showing 751 to 800 of 872

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Enzalutamide for hormone-relapsed non-metastatic prostate cancerTA580
Curos for preventing infections when using needleless connectorsMTG44
Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary careDG35
Crohn's disease: managementNG129
Ulcerative colitis: managementNG130
Intrapartum care for women with existing medical conditions or obstetric complications and their babiesNG121
Brentuximab vedotin for treating CD30-positive cutaneous T-cell lymphomaTA577
Certolizumab pegol for treating moderate to severe plaque psoriasisTA574
Bosutinib for untreated chronic myeloid leukaemia (terminated appraisal)TA576
Endoscopic ablation for an anal fistulaIPG645
Endoscopic ablation for a pilonidal sinusIPG646
Tildrakizumab for treating moderate to severe plaque psoriasisTA575
Specialist neonatal respiratory care for babies born pretermNG124
Ertugliflozin as monotherapy or with metformin for treating type 2 diabetesTA572
The Debrisoft monofilament debridement pad for use in acute or chronic woundsMTG17
Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinibTA571
Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (terminated appraisal)TA570
Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancerTA569
Abatacept for treating psoriatic arthritis after DMARDs (terminated appraisal)TA568
Radially emitting laser fibre treatment of an anal fistulaIPG644
Cochlear implants for children and adults with severe to profound deafnessTA566
Venetoclax with rituximab for previously treated chronic lymphocytic leukaemiaTA561
Encorafenib with binimetinib for unresectable or metastatic BRAF V600 mutation-positive melanomaTA562
Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancerTA563
High-intensity focused ultrasound for symptomatic benign thyroid nodulesIPG643
Bevacizumab with carboplatin, gemcitabine and paclitaxel for treating the first recurrence of platinum-sensitive advanced ovarian cancer (terminated appraisal)TA560
Barnett Continent Intestinal Reservoir (modified continent ileostomy) to restore continence after colon and rectum removalIPG642
Cough (acute): antimicrobial prescribingNG120
Electrically stimulated intravesical chemotherapy for non-muscle-invasive bladder cancerIPG638
Laparoscopic cerclage for cervical incompetence to prevent late miscarriage or preterm birthIPG639
Percutaneous venoplasty for chronic cerebrospinal venous insufficiency in multiple sclerosisIPG640
Platelet-rich plasma injections for knee osteoarthritisIPG637
Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic painMTG41
Ex-situ machine perfusion for extracorporeal preservation of livers for transplantationIPG636
Cerebral palsy in adultsNG119
Mepilex Border Heel and Sacrum dressings for preventing pressure ulcersMTG40
Regorafenib for previously treated advanced hepatocellular carcinomaTA555
Darvadstrocel for treating complex perianal fistulas in Crohn's diseaseTA556
Pipeline Flex embolisation device with Shield Technology for the treatment of complex intracranial aneurysmsMTG10
Renal and ureteric stones: assessment and managementNG118
Lenvatinib for untreated advanced hepatocellular carcinomaTA551
Liposomal cytarabine–daunorubicin for untreated acute myeloid leukaemiaTA552
Transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia in adultsIPG634
Bronchial thermoplasty for severe asthmaIPG635
Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribingNG117
Vandetanib for treating medullary thyroid cancerTA550
Decitabine for untreated acute myeloid leukaemia (terminated appraisal)TA548
Denosumab for preventing skeletal-related events in multiple myeloma (terminated appraisal)TA549
Post-traumatic stress disorderNG116
Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribingNG114

Results per page

  1. 10
  2. 25
  3. 50
  4. All